CiiTECH is proving to be at the top of the game in discovering, developing and commercializing cannabinoid products for the UK and global market over and over again. And they’ve done it again with the VapePod™!
Provacan, A CiiTECH brand, has launched the VapePod™ on its online shop. The VapePod™ is the UK’s first vape pen that has been certified as a medical cannabis device by the Israeli Ministry of Health, to be used with pre-filled Provacan CBD cartridges.
VapePod™, developed by Kanabo research, is certified as a safe and effective vaporisation system that inspires retailer and consumer confidence. It’s innovative features include accurate metered-dosing, allowing accurate terpene and cannabinoid consumption.
The medically validated device is operated with the Provacan pre-filled, no-mess cartridges formulated by CiiTECH together with Kanabo Research.
Proprietary DAY and NIGHT terpene-CBD formula is made with a THC free, broad spectrum Cannabis oil and made from EU compliant hemp strains ensuring full UK & EU compliance. They are enriched with CBD and CBG and developed in Israel in a GLP pharma grade facility. There are 2 distinct cannabis terpene formulations where one is the ‘Day’ formula to be used throughout a busy day and the ‘Night’ formula which compliments one’s evening routine.
The products are made using a patent-pending carrier solution that replaces the traditional e-liquids currently trending in the media for suspensions of releasing toxic materials when heated at high temperatures. Our neutral diluent allows for low irritation, high potency, and consistent dosing through the lifespan of the cartridge with an advanced bioavailability, as indicated by Kanabo pre-clinical trials.
CiiTECH Ltd. is a cannabis biotech company that focuses on discovering, developing and commercializing cannabinoid products for the global market. We do this by partnering and collaborating with leading institutions and companies to realise the full potential of cutting-edge cannabis innovation and bring it successfully to market. “For years it has been clear that best-of-breed cannabis research and product development is happening in Israel. Our customers demand a level of trust in CBD products that we are able to meet through both our own research and collaborations. There’s a real growth in consumer understanding of the terpenes. We believe our proven formulas together with the VapePod™ device deliver an exceptional level of CBD innovation and efficacy not previously seen in the industry.” says Clifton Flack, CiiTECH CEO and founder.
For more information on VapePod visit: www.vapepod.com
